Cenario Pharma Private Limited
About Cenario Pharma Private Limited
Data last updated:
Cenario Pharma Private Limited is a private limited company based in Faridabad, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 01 February 2022.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2022PTC100994.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kunvar Siddharth Singh and Reetoo Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 77 Gali No. 5 Harkesh Nagar Tilpat, Faridabad, Haryana, India – 121003.
As per the financials filed for FY 2024, the company reported a revenue of ₹7 Lakh, a growth of 124% compared to the previous year. For the same year it recorded a net profit of ₹26,676 (net margin 3.8%) and EBITDA of ₹26,676 (EBITDA margin 3.8%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No. 77 Gali No. 5 Harkesh Nagar Tilpat, Faridabad, Haryana, India – 121003
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Cenario Pharma Private Limited
The main business activity of Cenario Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cenario Pharma Private Limited FY 2025 filings available
Cenario Pharma Private Limited reported revenue of ₹7 Lakh (up 124% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Cenario Pharma Private Limited
Revenue rose 124% in the latest year. EBITDA rose 966% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Cenario Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹26,676 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹26,676 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Cenario Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.8% | •••• | •••• |
| Net Profit Margin | 3.8% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cenario Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Cenario Pharma Private Limited
Cenario Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kunvar Siddharth Singh | Director | 01 Feb 2022 | 4 Years 8 Months | Current |
| Reetoo Singh | Director | 01 Feb 2022 | 4 Years 8 Months | Current |
Peer Comparison of Cenario Pharma Private Limited
Cenario Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Huntsey Bright Agro Private Limited | ₹7 Lakh (FY 2019) | •••• | •••• | •••• | Kundapura, Karnataka, India | |
| Maexon Petroleum Industries Private Limited | ₹7 Lakh (FY 2024) | •••• | •••• | •••• | Motihari, Bihar, India | |
| Patni Sortech Private Limited | ₹7 Lakh (FY 2024) | •••• | •••• | -61.0% | •••• | Jaipur, Rajasthan, India |
| Majestic Dealmark Private Limited | ₹7 Lakh (FY 2025) | •••• | •••• | 15.0% | •••• | Kolkata, West Bengal, India |
| Bio Revolution India Private Limited | ₹7 Lakh (FY 2023) | •••• | •••• | -3.0% | •••• | Pune, Maharashtra, India |
| Cenario Pharma Private Limited this company | ₹7 Lakh (FY 2024) | •••• | •••• | 124.0% | •••• | Faridabad, Haryana, India |
| S.K. Retreats Private Limited | ₹7 Lakh (FY 2025) | •••• | •••• | -31.0% | •••• | New Delhi, Delhi, India |
| Aksar Trading Private Limited | ₹6.99 Lakh (FY 2020) | •••• | •••• | -48.0% | •••• | Delhi, India |
| Mion Plast Private Limited | ₹6.99 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Mumbai, Maharashtra, India |
| Diansh Life Sciences Private Limited | ₹6.99 Lakh (FY 2023) | •••• | •••• | 977.0% | •••• | Lucknow, Uttar Pradesh, India |
| Sapient Instruments Private Limited | ₹6.99 Lakh (FY 2024) | •••• | •••• | -38.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Cenario Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Cenario Pharma Private Limited
Cenario Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cenario Pharma Private Limited
Employment history and EPFO contributions of people linked to Cenario Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cenario Pharma Private Limited
Cenario Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Kunvar Siddharth Singh was appointed as Director on 01 Feb 2022.
Credit Ratings, Litigation & Regulatory Alerts for Cenario Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cenario Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cenario Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cenario Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cenario Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cenario Pharma Private Limited
Cenario Pharma is an active private limited company based in Faridabad, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 01 February 2022 (4+ years old) and is registered under CIN U24290HR2022PTC100994.
Cenario Pharma reported revenue of ₹7 Lakh for FY 2024 (up 124% YoY).
Cenario Pharma has 2 current directors:
- Kunvar Siddharth Singh - Director
- Reetoo Singh - Director
Cenario Pharma reported a net profit of ₹26,676 (net margin 3.8%) and EBITDA of ₹26,676 (EBITDA margin 3.8%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Cenario Pharma is U24290HR2022PTC100994. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cenario Pharma was incorporated on 01 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Cenario Pharma by revenue are Huntsey Bright Agro Private Limited, Maexon Petroleum Industries Private Limited, Patni Sortech Private Limited, Majestic Dealmark Private Limited, Bio Revolution India Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Kunvar Siddharth Singh was appointed as Director on 01 Feb 2022. Reetoo Singh was appointed as Director on 01 Feb 2022.
The registered office of Cenario Pharma is at House No. 77 Gali No. 5 Harkesh Nagar Tilpat, Faridabad, Haryana, India – 121003.
Cenario Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Cenario Pharma operates in the chemicals industry, in the manufacturing segment.